Skip to main content
. 2018 Jan 4;26(3):744–754. doi: 10.1016/j.ymthe.2017.12.023

Figure 7.

Figure 7

Therapeutic Mechanism of miR-145 Delivery to Overcome SNAI1-Mediated Colorectal Cancer Radiation Resistance

SNAI1 can activate Nanog and repress miR-145. Thus, SNAI1 mediates the CSC program, resulting in a radiation-resistant colorectal cancer cell population. Delivery of miR-145 to target multiple stemness genes, including Nanog, KLF4, and c-Myc, can impair CSC self-renewal capacity and increase sensitivity of radiation therapy.